🇺🇸 FDA
Patent

US 10202367

Heterocyclic compounds and methods of use thereof

granted A61KA61K31/4178A61K31/454

Quick answer

US patent 10202367 (Heterocyclic compounds and methods of use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/4178, A61K31/454, A61K31/4545, A61K31/496